Prazitone
From Self-sufficiency
200px | |
Systematic (IUPAC) name | |
---|---|
5-phenyl-5-(piperidin-2-ylmethyl)pyrimidine-2,4,6(1H,3H,5H)-trione | |
Identifiers | |
CAS Number | 2409-26-9 |
ATC code | none |
PubChem | CID 3050417 |
Synonyms | Prazitone, AGN-511, 5-Phenyl-5-(2-piperidylmethyl)barbituric acid |
Chemical data | |
Formula | C16H19N3O3 |
Molar mass | 301.34 g/mol[[Script error: No such module "String".]] |
Prazitone (AGN-511) is a barbiturate derivative invented in the 1970s. Unlike most barbiturates, it has little or no sedative effects, instead acting as a non-sedating anxiolytic and antidepressant.[1] The dosage range in humans is around 200-600mg, although higher doses have been used in trials for the treatment of depression associated with Parkinson's disease.
References
- ↑ Ross Langlands. Method for imparting anti-depressant and/or anxiolytic effects to animals. US Patent 3,806,596
This pharmacology-related article is a stub. You can help ssf by expanding it. |
Categories:
- Pages with script errors
- Pages with broken file links
- Infobox drug tracked parameters
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs not assigned an ATC code
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Pharmacology stubs
- Barbiturates
- Piperidines
- 2Fix